Literature DB >> 12240946

Mechanism of corneal permeation of L-valyl ester of acyclovir: targeting the oligopeptide transporter on the rabbit cornea.

Banmeet S Anand1, Ashim K Mitra.   

Abstract

PURPOSE: To delineate mechanisms associated with the corneal transport of a L-valine prodrug of an antiviral agent, acyclovir.
METHOD: The permeability and enzymatic hydrolysis of L-Val-ACV were evaluated using freshly excised rabbit cornea. Transport mechanism across rabbit cornea was investigated through a competitive inhibition study of L-Val-ACV with other substrates of human peptide transporter (hPepT1).
RESULTS: L-Valyl ester of Acyclovir (L-Val-ACV) was approximately threefold more permeable across the intact rabbit cornea than acyclovir (ACV). Dipeptides, beta-lactam antibiotics, and angiotensin converting enzyme (ACE) inhibitors, strongly inhibited the transport of L-Val-ACV indicating that a carrier mediated transport system specific for peptides is primarily responsible for the corneal permeation of L-Val-ACV. L-Val-ACV transport was found to be saturable (Km = 2.26 +/- 0.34 mM, Jmax = 1.087 +/- 0.05 nmoles cm(-2) min(-1)), energy and pH dependent. CONCLUSIONS Functional evidence of an oligopeptide transport system present on the rabbit cornea has been established. The peptide transporter on the corneal epithelium may be targeted to improve the ocular bioavailability of poorly absorbed drugs.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12240946     DOI: 10.1023/a:1019806411610

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  31 in total

Review 1.  Drug transport and targeting. Intestinal transport.

Authors:  D M Oh; H K Han; G L Amidon
Journal:  Pharm Biotechnol       Date:  1999

2.  Transport of valganciclovir, a ganciclovir prodrug, via peptide transporters PEPT1 and PEPT2.

Authors:  M Sugawara; W Huang; Y J Fei; F H Leibach; V Ganapathy; M E Ganapathy
Journal:  J Pharm Sci       Date:  2000-06       Impact factor: 3.534

3.  Characterization of an oligopeptide transporter in renal lysosomes.

Authors:  X Zhou; M Thamotharan; A Gangopadhyay; C Serdikoff; S A Adibi
Journal:  Biochim Biophys Acta       Date:  2000-06-01

4.  Transport of L-valine-acyclovir via the oligopeptide transporter in the human intestinal cell line, Caco-2.

Authors:  R L de Vrueh; P L Smith; C P Lee
Journal:  J Pharmacol Exp Ther       Date:  1998-09       Impact factor: 4.030

5.  Effect of ionization on the variable uptake of valacyclovir via the human intestinal peptide transporter (hPepT1) in CHO cells.

Authors:  P Balimane; P Sinko
Journal:  Biopharm Drug Dispos       Date:  2000-07       Impact factor: 1.627

6.  Effect of mono- and di-acylation on the ocular disposition of ganciclovir: physicochemical properties, ocular bioreversion, and antiviral activity of short chain ester prodrugs.

Authors:  Clapton S Dias; Banmeet S Anand; Ashim K Mitra
Journal:  J Pharm Sci       Date:  2002-03       Impact factor: 3.534

7.  Mechanism of acyclovir uptake in rat jejunum.

Authors:  K C Meadows; J B Dressman
Journal:  Pharm Res       Date:  1990-03       Impact factor: 4.200

8.  Human intestinal H+/peptide cotransporter. Cloning, functional expression, and chromosomal localization.

Authors:  R Liang; Y J Fei; P D Prasad; S Ramamoorthy; H Han; T L Yang-Feng; M A Hediger; V Ganapathy; F H Leibach
Journal:  J Biol Chem       Date:  1995-03-24       Impact factor: 5.157

Review 9.  Acyclovir. A review of its pharmacodynamic properties and therapeutic efficacy.

Authors:  D M Richards; A A Carmine; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1983-11       Impact factor: 9.546

10.  Cellular uptake mechanism of amino acid ester prodrugs in Caco-2/hPEPT1 cells overexpressing a human peptide transporter.

Authors:  H K Han; D M Oh; G L Amidon
Journal:  Pharm Res       Date:  1998-09       Impact factor: 4.200

View more
  23 in total

Review 1.  Ocular drug delivery.

Authors:  Ripal Gaudana; Hari Krishna Ananthula; Ashwin Parenky; Ashim K Mitra
Journal:  AAPS J       Date:  2010-05-01       Impact factor: 4.009

Review 2.  Prodrug strategies in ocular drug delivery.

Authors:  Megha Barot; Mahuya Bagui; Mitan R Gokulgandhi; Ashim K Mitra
Journal:  Med Chem       Date:  2012-07       Impact factor: 2.745

Review 3.  Phase I and phase II ocular metabolic activities and the role of metabolism in ophthalmic prodrug and codrug design and delivery.

Authors:  Abeer M Al-Ghananeem; Peter A Crooks
Journal:  Molecules       Date:  2007-03-08       Impact factor: 4.411

4.  Immunohistochemical and functional characterization of peptide, organic cation, neutral and basic amino acid, and monocarboxylate drug transporters in human ocular tissues.

Authors:  Rajendra S Kadam; Sunil K Vooturi; Uday B Kompella
Journal:  Drug Metab Dispos       Date:  2012-11-20       Impact factor: 3.922

Review 5.  Novel strategies for anterior segment ocular drug delivery.

Authors:  Kishore Cholkar; Sulabh P Patel; Aswani Dutt Vadlapudi; Ashim K Mitra
Journal:  J Ocul Pharmacol Ther       Date:  2012-12-05       Impact factor: 2.671

6.  Novel biotinylated lipid prodrugs of acyclovir for the treatment of herpetic keratitis (HK): transporter recognition, tissue stability and antiviral activity.

Authors:  Aswani Dutt Vadlapudi; Ramya Krishna Vadlapatla; Ravinder Earla; Suman Sirimulla; Jake Brain Bailey; Dhananjay Pal; Ashim K Mitra
Journal:  Pharm Res       Date:  2013-05-09       Impact factor: 4.200

Review 7.  Ocular cytochrome P450s and transporters: roles in disease and endobiotic and xenobiotic disposition.

Authors:  Mariko Nakano; Catherine M Lockhart; Edward J Kelly; Allan E Rettie
Journal:  Drug Metab Rev       Date:  2014-05-26       Impact factor: 4.518

Review 8.  A comprehensive insight on ocular pharmacokinetics.

Authors:  Vibhuti Agrahari; Abhirup Mandal; Vivek Agrahari; Hoang M Trinh; Mary Joseph; Animikh Ray; Hicheme Hadji; Ranjana Mitra; Dhananjay Pal; Ashim K Mitra
Journal:  Drug Deliv Transl Res       Date:  2016-12       Impact factor: 4.617

Review 9.  Advances in the use of prodrugs for drug delivery to the eye.

Authors:  Pranjal Taskar; Akshaya Tatke; Soumyajit Majumdar
Journal:  Expert Opin Drug Deliv       Date:  2016-07-21       Impact factor: 6.648

10.  Ocular pharmacokinetics of acyclovir amino acid ester prodrugs in the anterior chamber: evaluation of their utility in treating ocular HSV infections.

Authors:  Suresh Katragadda; Sriram Gunda; Sudharshan Hariharan; Ashim K Mitra
Journal:  Int J Pharm       Date:  2008-03-22       Impact factor: 5.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.